Macrogen, Inc. (038290.KQ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 5Aug 10Aug 13Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

11.4x

Market Cap

KRW 131.72B

MomentumView details →

1D Return

−1.70%

YTD Return

−27.09%

RSI (14)

48.7

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

11.4x

Market Cap

KRW 131.72B

RSI (14)

48.7

MomentumView details →

1D Return

−1.70%

YTD Return

−27.09%

ProfitabilityView details →

Gross Margin

37.03%

Net Margin

5.11%

EBITDA Margin

8.41%

ROE (TTM)

6.62%

ROA (TTM)

2.78%

Asset Turnover

0.55x

GrowthView details →

Revenue YoY

+23.00%

EPS YoY

+256.92%

FCF YoY

+106.07%

Revenue CAGR 3Y

+12.10%

EPS CAGR 3Y

+124.56%

EBITDA YoY

−58.86%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

KRW 0.00

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.71x

Current Ratio

0.85x

Quick Ratio

0.68x

Div Yield

2.47%

Div Rate

KRW 300.00

Div Growth 1Y

+0.00%

Financials snapshotView financials →

Revenue (TTM)

201.62B

Net Income (TTM)

10.29B

Op. CF (TTM)

32.34B

Latest newsMore news →

No recent news for 038290.KQ.

Similar companies

Helixmith Co., Ltd084990.KQ Vertex Pharmaceuticals IncorporatedVRTX Anterogen.Co.,Ltd.065660.KQ Genexine, Inc.095700.KQ Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.06990.HK ORIENT BIO Inc.002630.KS Find similar companies →

Latest newsMore news →

No recent news for 038290.KQ.